Evidence map›Paper›PMID 40156338›Full record

ArticleInternational journal of urology : official journal of the Japanese Urological Association2025

Water Vapor Energy Therapy Safely Reduces Urinary Medication Use: A Multicenter Retrospective Real-World Study in Japan (SCCOP Study 24-01).

Junya Abe, Yuki Kyoda, Kazunori Haga, Takumi Sasao, Daito Nishiyama, Seisuke Nofuji, Koji Ichihara, Yohei Matsuda, Tomohiro Toyota, Yohei Ueki and 7 more

Abstract readMulticenter Study
In one paragraph

Article in International journal of urology : official journal of the Japanese Urological Association, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 6 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
6citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

6 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

17 authors.

Junya AbeDepartment of Urology, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan.ORCID https://orcid.org/0009-0003-7486-1831
Yuki KyodaDepartment of Urology, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan.ORCID https://orcid.org/0000-0003-2046-5051
Kazunori HagaSanjukai Urological Hospital, Sapporo, Hokkaido, Japan.ORCID https://orcid.org/0009-0001-7618-6783
Takumi SasaoSaka Urological Hospital, Sapporo, Hokkaido, Japan.
Daito NishiyamaDepartment of Urology, NTT East Sapporo Hospital, Sapporo, Hokkaido, Japan.
Seisuke NofujiDepartment of Urology, NTT East Sapporo Hospital, Sapporo, Hokkaido, Japan.
Koji IchiharaDepartment of Urology, Sapporo Central Hospital, Sapporo, Hokkaido, Japan.ORCID https://orcid.org/0000-0002-4651-1469
Yohei MatsudaDepartment of Urology, Tomakomai Urological and Cardiological Clinic, Tomakomai, Hokkaido, Japan.
Tomohiro ToyotaDepartment of Urology, JCHO Hokkaido Hospital, Sapporo, Hokkaido, Japan.
Yohei UekiDepartment of Urology, JCHO Hokkaido Hospital, Sapporo, Hokkaido, Japan.
Shuto KontaDepartment of Urology, Nemuro City Hospital, Nemuro, Hokkaido, Japan.
Sho NakayamaDepartment of Urology, Asahikawa Red Cross Hospital, Asahikawa, Hokkaido, Japan.
Jurai ShibuyaDepartment of Urology, Steel Memorial Muroran Hospital, Muroran, Hokkaido, Japan.
Genki KobayashiDepartment of Urology, Hakodate Goryokaku Hospital, Hakodate, Hokkaido, Japan.
Takeshi MaehanaDepartment of Urology, Hokkaido Medical Center, Sapporo, Hokkaido, Japan.ORCID https://orcid.org/0000-0003-2687-1923
Yusuke NakajimaDepartment of Urology, Takikawa Municipal Hospital, Takikawa, Hokkaido, Japan.
Naoya MasumoriDepartment of Urology, Sapporo Medical University School of Medicine, Sapporo, Hokkaido, Japan.ORCID https://orcid.org/0000-0001-6324-0739

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

objectiveThe Japanese guidelines for male lower urinary tract symptoms (LUTS) and benign prostatic hyperplasia (BPH) recommend the water vapor energy therapy (WAVE) procedure only for patients in whom conventional BPH surgery is unsuitable due to advanced age or comorbidities. This study aims to evaluate the efficacy and safety of the WAVE procedure using the Rezum system in Japan.

methodsThis multicenter retrospective study included patients who underwent the WAVE procedure between August 2022 and December 2023. A total of 311 patients from 13 institutions were registered. The number of medications for LUTS was determined before surgery and 6 months after surgery. Additionally, voiding function and perioperative complications were analyzed.

resultsOf the 311 patients, 291 were eligible for analysis. The mean number of LUTS medications significantly decreased from 1.4 to 0.6 (p < 0.001). The mean maximum urinary flow rate significantly improved from 9.8 mL/s preoperatively to 12.2 mL/s at 6 months postoperatively (p < 0.001). The mean post-void residual volume also significantly decreased from 124 to 78 mL (p < 0.001). Furthermore, the mean total International Prostate Symptom Score significantly improved from 17.8 to 8.9 (p < 0.001). Complications classified as Clavien-Dindo Grade III or higher occurred in four cases (1.2%).

conclusionThis large-scale, multicenter study demonstrates that the WAVE procedure improves LUTS, reduces the number of LUTS medications, and is both effective and safe for elderly patients with multiple comorbidities in Japan.

Indexed as

Lower Urinary Tract SymptomsProstatic HyperplasiaAgedAged, 80 and overHumansJapanMaleMiddle AgedPostoperative ComplicationsRetrospective StudiesSteamTreatment OutcomeSteambenign prostatic hyperplasiaJapaneseminimally invasive surgical therapyreal‐world

Identifiers

PMID40156338
PMCPMC12230878

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.